Quoin Pharmaceuticals, Ltd. (QNRX) Reports Q2 Loss of $3.24/sh
Tweet
Share
E-mailGet Alerts QNRX Hot Sheet
Join SI Premium – FREE
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) reported Q2 EPS of ($3.24), versus ($18.05) reported last year.
For earnings history and earnings-related data on Quoin Pharmaceuticals, Ltd. (QNRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030
- MVB Bank partners with DingoBlu on mobile banking platform
- Bernstein sees downside risk to Apple's December quarter results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
